Cancer frenemy pathways: Inducing immunogenic cell death by exploiting apoptosis-interferon antagonism with oncolytic viruses
Molecular Therapy Oncology · 2026-06 · 34 (2) · 201211
DOI: 10.1016/j.omton.2026.201211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy Oncology, 2026-06. Verfasst von Vladimir Bozhdansky und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel-Aviv 6997801, Israel. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tel Aviv University, Israel Science Foundation, Israel Ministry of Innovation Science & Technology.
Abstract (Originalsprache)
The term “frenemy,” a portmanteau of “friend” and “enemy,” describes a relationship that blends cooperation and antagonism, with overt collaboration often masking underlying tension.1 Analogously, many signaling pathways and biological programs that preserve tissue integrity in normal contexts assume ambivalent roles in cancer, simultaneously sustaining tumor survival while encoding vulnerabilities exploitable therapeutically. Within this framework, synthetic lethality, originally defined in classical genetics as a condition where combined disruption of two genes is lethal whereas perturbation of either alone is tolerated, has expanded from discrete gene pairs to encompass interactions among pathways, functional states, and higher-order processes.
Autor:innen und Institutionen
- The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel-Aviv 6997801, Israel.
Förderung
- Tel Aviv University
- Israel Science Foundation
- Israel Ministry of Innovation Science & Technology
- Tel Aviv University Cancer Biology Research Center
- Ministry of Science and Technology, Israel
Zitieren
APA
Bozhdansky, V., Bacharach, E., & Ehrlich, M. (2026). Cancer frenemy pathways: Inducing immunogenic cell death by exploiting apoptosis-interferon antagonism with oncolytic viruses. Molecular Therapy Oncology, 34(2), 201211. https://doi.org/10.1016/j.omton.2026.201211
Vancouver
Bozhdansky V, Bacharach E, Ehrlich M. Cancer frenemy pathways: Inducing immunogenic cell death by exploiting apoptosis-interferon antagonism with oncolytic viruses. Molecular Therapy Oncology. 2026;34(2):201211. doi:10.1016/j.omton.2026.201211
BibTeX
@article{Bozhdansky2026,
author = {Bozhdansky, Vladimir and Bacharach, Eran and Ehrlich, Marcelo},
title = {Cancer frenemy pathways: Inducing immunogenic cell death by exploiting apoptosis-interferon antagonism with oncolytic viruses},
journal = {Molecular Therapy Oncology},
year = {2026},
volume = {34},
number = {2},
pages = {201211},
doi = {10.1016/j.omton.2026.201211}
}
EUVIMED